Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene, catalogued as ENSG00000285081, represents a novel non-coding transcript located within an intron of the CPVL gene. It is labelled "sense intronic to CPVL" meaning the transcript overlaps the CPVL gene in the sense orientation but is not protein-coding. There are no published studies or functional characterizations directly associating this transcript to a protein, receptor, therapeutic target, or disease biology. Its existence is based only on transcriptomic annotation and not on experimental evidence of function, protein expression, or target-related properties. The CPVL gene itself encodes a probable serine carboxypeptidase that may play a role in antigen processing, secretory pathways, and is implicated as a biomarker in some disease contexts. However, ENSG00000285081 refers to an intronic RNA, not the protein-coding CPVL gene. The "novel transcript" is a placeholder for a potentially uncharacterized or poorly understood non-coding RNA. There is no evidence for its utility as a drug target, biomarker, receptor, or mechanism for drug action. ENSG00000285081 is not a recognized therapeutic target, but rather a non-coding transcript without established function, mechanism, or pharmacological relevance. If you are seeking information on the CPVL enzyme itself, which is implicated in antigen processing and inflammation, refer to the gene symbol CPVL (Carboxypeptidase vitellogenic-like).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to CPVL (ENSG00000285081).